These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1941882)

  • 1. Changes in vascular morphology in essential hypertension.
    Heagerty AM
    J Hum Hypertens; 1991 Aug; 5 Suppl 1():3-8. PubMed ID: 1941882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive treatment on small artery remodelling.
    Agabiti-Rosei E; Heagerty AM; Rizzoni D
    J Hypertens; 2009 Jun; 27(6):1107-14. PubMed ID: 19293726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early structural changes in hypertension: pathophysiology and clinical consequences.
    Folkow B
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S1-6. PubMed ID: 7507535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trandolapril in patients with essential hypertension: effects on vascular and cardiac structural changes.
    Rendina V; Iaccarino G; Russo R; Enea J; Marchegiano R; Lembo G; Trimarco B
    J Cardiovasc Pharmacol; 1994; 23 Suppl 1():S20-4. PubMed ID: 7519692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of antihypertensive treatment on vascular remodeling in essential hypertensive patients.
    Schiffrin EL; Deng LY; Larochelle P
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S51-6. PubMed ID: 7700067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New goals in hypertension management: target-organ protection beyond blood pressure lowering].
    Safar ME; Struijker-Boudier HA
    Drugs; 2003; 63 Spec No 1():45-7. PubMed ID: 12708882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural changes in hypertension, the potential for their prevention, arrest and reversal: a focus on felodipine.
    Purcell H; Coats A
    Br J Clin Pract; 1994; 48(6):311-6. PubMed ID: 7848795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical and other factors involved in vascular injury related to hypertension.
    Mulvany MJ
    Blood Press Suppl; 1994; 1():11-7. PubMed ID: 8205292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular and microvascular hypertrophy in essential hypertension: clinical relevance and prognostic implications.
    Thürmann PA
    Int J Clin Pharmacol Ther; 1997 May; 35(5):181-7. PubMed ID: 9174872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of hypertrophy of resistance vessels in humans in different stages of hypertension.
    Prerovský I; Romanovská L; Stríbrná J
    Czech Med; 1980; 3(1):36-42. PubMed ID: 7358012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic resistance of forearm vessels during prolonged drug treatment of essential hypertension.
    Vitols AV; Skarda IJ; Liepinia DJ; Voita DU; Skards JV
    Cor Vasa; 1990; 32(1):36-44. PubMed ID: 2340728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remodelling of conduit arteries in hypertension: special emphasis on the mechanical and metabolic consequences of vascular hypertrophy.
    Hayoz D; Brunner HR
    Blood Press Suppl; 1997; 2():39-42. PubMed ID: 9495625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major new developments affecting treatment and prognosis in hypertension.
    Gubner RS
    Trans Assoc Life Insur Med Dir Am; 1990; 73():97-114. PubMed ID: 2353405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression of hypertrophy in small resistance vessels.
    Sano T; Tarazi RC
    J Hypertens Suppl; 1985 Dec; 3(3):S489-91. PubMed ID: 2856775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertension as a risk factor syndrome: therapeutic implications.
    Weber MA
    Am J Med; 1993 Apr; 94(4A):24S-31S. PubMed ID: 8488853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.